Gheytanchi E - Search Results

1

Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review.

Razmi M, Hashemi F, Gheytanchi E, Dehghan Manshadi M, Ghods R, Madjd Z. Razmi M, et al. Among authors: gheytanchi e. Int Immunopharmacol. 2020 Nov;88:106942. doi: 10.1016/j.intimp.2020.106942. Epub 2020 Aug 29. Int Immunopharmacol. 2020. PMID: 32896750 Free PMC article.

2

Application of stem cells in targeted therapy of breast cancer: a systematic review.

Madjd Z, Gheytanchi E, Erfani E, Asadi-Lari M. Madjd Z, et al. Among authors: gheytanchi e. Asian Pac J Cancer Prev. 2013;14(5):2789-800. doi: 10.7314/apjcp.2013.14.5.2789. Asian Pac J Cancer Prev. 2013. PMID: 23803033 Free article. Review.

3

ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.

Keymoosi H, Gheytanchi E, Asgari M, Shariftabrizi A, Madjd Z. Keymoosi H, et al. Among authors: gheytanchi e. Asian Pac J Cancer Prev. 2014;15(5):2013-20. doi: 10.7314/apjcp.2014.15.5.2013. Asian Pac J Cancer Prev. 2014. PMID: 24716927 Free article.

4

Expression of Ki-67, p53 and VEGF in pediatric neuroblastoma.

Gheytanchi E, Mehrazma M, Madjd Z. Gheytanchi E, et al. Asian Pac J Cancer Prev. 2014;15(7):3065-70. doi: 10.7314/apjcp.2014.15.7.3065. Asian Pac J Cancer Prev. 2014. PMID: 24815448 Free article.

5

Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.

Sedaghat S, Gheytanchi E, Asgari M, Roudi R, Keymoosi H, Madjd Z. Sedaghat S, et al. Among authors: gheytanchi e. Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):196-202. doi: 10.1097/PAI.0000000000000291. Appl Immunohistochem Mol Morphol. 2017. PMID: 26945449

6

Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis.

Madjd Z, Erfani E, Gheytanchi E, Moradi-Lakeh M, Shariftabrizi A, Asadi-Lari M. Madjd Z, et al. Among authors: gheytanchi e. Int J Biol Markers. 2016 May 28;31(2):e118-25. doi: 10.5301/jbm.5000209. Int J Biol Markers. 2016. PMID: 27102864 Free article. Review.

7

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.

Gheytanchi E, Madjd Z, Janani L, Rasti A, Ghods R, Atyabi F, Asadi-Lari MH, Babashah S. Gheytanchi E, et al. Syst Rev. 2017 Nov 17;6(1):228. doi: 10.1186/s13643-017-0624-2. Syst Rev. 2017. PMID: 29149908 Free PMC article.

8

Low expression of Talin1 is associated with advanced pathological features in colorectal cancer patients.

Vafaei S, Saeednejad Zanjani L, Habibi Shams Z, Naseri M, Fattahi F, Gheytanchi E, Alemrajabi M, Ebrahimi M, Madjd Z. Vafaei S, et al. Among authors: gheytanchi e. Sci Rep. 2020 Oct 20;10(1):17786. doi: 10.1038/s41598-020-74810-6. Sci Rep. 2020. PMID: 33082414 Free PMC article.

9

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma.

Rezaee M, Gheytanchi E, Madjd Z, Mehrazma M. Rezaee M, et al. Among authors: gheytanchi e. Iran J Pathol. 2021 Winter;16(1):40-50. doi: 10.30699/ijp.2020.127441.2389. Epub 2020 Oct 10. Iran J Pathol. 2021. PMID: 33391379 Free PMC article.

10

High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.

Gheytanchi E, Saeednejad Zanjani L, Ghods R, Abolhasani M, Shahin M, Vafaei S, Naseri M, Fattahi F, Madjd Z. Gheytanchi E, et al. J Cancer Res Clin Oncol. 2021 Jun;147(6):1631-1646. doi: 10.1007/s00432-021-03561-2. Epub 2021 Feb 22. J Cancer Res Clin Oncol. 2021. PMID: 33616717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters